v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 1,279.7 $ 1,557.1
Marketable investments 874.0 1,363.2
Accounts receivable, no allowance for 2026 and 2025 312.0 350.2
Inventories, net 178.3 183.1
Other current assets 228.0 248.9
Total current assets 2,872.0 3,702.5
Marketable investments 1,317.4 1,776.7
Goodwill and other intangible assets, net 115.5 116.5
Property, plant, and equipment, net 1,840.7 1,729.7
Deferred tax assets, net 335.4 357.7
Other non-current assets 233.2 196.9
Total assets 6,714.2 7,880.0
Current liabilities:    
Accounts payable and accrued expenses 498.3 488.0
Other current liabilities 100.8 72.6
Total current liabilities 599.1 560.6
Other non-current liabilities 214.0 223.2
Total liabilities 813.1 783.8
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, par value $.01, 10,000,000 shares authorized, no shares issued 0.0 0.0
Common stock, par value $.01, 245,000,000 shares authorized, 77,129,770 and 76,452,253 shares issued, and 42,156,223 and 43,643,165 shares outstanding as of March 31, 2026 and December 31, 2025, respectively 0.8 0.8
Additional paid-in capital 2,520.3 2,798.0
Accumulated other comprehensive (loss) income (10.2) 0.9
Treasury stock, 34,973,547 and 32,809,088 shares as of March 31, 2026 and December 31, 2025, respectively (5,441.6) (4,260.4)
Retained earnings 8,831.8 8,556.9
Total stockholders’ equity 5,901.1 7,096.2
Total liabilities and stockholders’ equity $ 6,714.2 $ 7,880.0